News | February 04, 2013

Biotronik Launches the 3Flow Aspiration Catheter for Improved Thrombus Aspiration

The catheter’s features, which include one of the market’s largest extraction lumen and locking syringe, allow for quick, easy and accurate thrombus aspiration

3Flow Aspiration Catheter Thrombectomy Devices Biotronik Inc. Europe

February 4, 2013 — Biotronik recently launched its 3Flow Aspiration Catheter in Europe. The catheter is specifically designed to facilitate quick and accurate thrombus aspiration, complementing Biotronik’s already broad coronary vascular intervention (CVI) portfolio.

Thrombus aspiration is applicable in a larger majority of patients with myocardial infarction with ST-segment elevation (STEMI). Acute ST-segment elevation indicates that a relatively large amount of heart muscle damage is occurring because thrombus occludes an epicardial artery. Thrombus aspiration significantly improves the clinical outcome in STEMI patients and has received a IIa recommendation in the most recent ESC guidelines (European Society of Cardiology).

The 3Flow Catheter’s features differentiate it from other catheters on the market: With the supplied 60ml locking syringe and large inner lumen, the 3Flow Catheter allows for the extraction of larger thrombotic particles — as well as for a longer aspiration time. Its hydrophilic distal coating and smooth tip design furthermore ensure that excellent deliverability and optimal kink resistance are provided by the proximal high performance thermoplastic polymer shaft.

“The large syringe doubles the aspiration time compared to standard 30 mL syringes, which avoids switching syringes in many cases and allows to better focus on the accuracy of the procedure,” says Dr. Henrik Schneider from the University Hospital in Rostock, Germany. “At the same time, the large inner lumen catheter allows for aspiration of larger thrombotic particles and causes less blockages.”

“For STEMI patients, 3Flow is an ideal extension to our stent and balloon portfolio. In this very critical patient segment, a proper lesion preparation is as always key to successful stenting”, says Alain Aimonetti, vice president sales and business development, Biotronik Vascular Intervention. 

Related Content

JETi Thrombectomy System Safe and Effective for Deep Vein Thrombosis
News | Thrombectomy Devices | February 12, 2019
A study presented at the 2018 annual meeting of the Cardiovascular and Interventional Radiology Society of Europe (...
Delayed Clot Removal Still Improves Quality of Life Post-Stroke
News | Thrombectomy Devices | February 05, 2019
Stroke survivors have better quality of life three months after their stroke if the clot that caused the stroke was...
An assortment of Boston Scientific AngioJet rheolytic thrombectomy catheters. These devices use high-velocity saline jets to entrain thrombus, resulting in microfragmentation and removal. Thrombectomy is also referred to as embolectomy.

An assortment of Boston Scientific AngioJet rheolytic thrombectomy catheters. These devices use high-velocity saline jets to entrain thrombus, resulting in microfragmentation and removal.

Feature | Thrombectomy Devices | January 22, 2019 | Dave Fornell, Editor
Catheter-based blood clot removal a decade ago was a standard of care for acute coronary revascularization, but decli
Cerenovus Launches Global Registry for EmboTrap II Revascularization Device
News | Thrombectomy Devices | January 16, 2019
Cerenovus, of Johnson & Johnson Medical Devices Companies, recently launched the EXCELLENT Registry to collect and...
First Commercial Ekos Control Unit 4.0 Products Shipped to Europe
News | Thrombectomy Devices | November 21, 2018
November 21, 2018 — BTG plc announced the first Ekos CU 4.0 units have been shipped from BTG’s facility in Bothell, W
Medtronic MindFrame Capture LP Revascularization Device Recalled.
News | Thrombectomy Devices | May 21, 2018
Medtronic and the U.S. Food and Drug Administration (FDA) announced a Class I Urgent Medical Device Recall of the...
Stryker Trevo Retriever Thrombectomy Device Approved for Stroke Treatment Up to 24 Hours
Technology | Thrombectomy Devices | February 15, 2018
The U.S. Food and Drug Administration (FDA) has expanded the indication for Stryker's Trevo Retriever as a front-line...
Brain-scan guided emergency stroke treatment can save more lives
News | Thrombectomy Devices | January 25, 2018
January 25, 2018 – Advances in brain imaging can identify a greater number of stroke patients who can receive therapy
global thrombectomy devices market, Allied Market Research report, 2022
News | Thrombectomy Devices | January 05, 2017
January 5, 2017 — A new report published by Allied Market Research forecasts that the global...
Neuravi, EmboTrap II stent retriever, thrombectomy device, acute stroke, European launch, CE Mark
News | Thrombectomy Devices | September 28, 2016
Neuravi recently announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available...
Overlay Init